M. Shaidorov

The efficacy of the combination of eribulin and trastuzumab in advanced HER2-positive breast cancer: the results of Russian observational study

N. O. Popova, O. S. Frolova, E. Kovalenko, 2020, Journal of Modern Oncology.

Efficacy and safety of eribulin in HER2-negative metastatic breast cancer: the results of long-term experience in real clinical practice in Russia

L. Bolotina, V. Gorbunova, E. Ovchinnikova, 2019, Journal of Modern Oncology.

The potential of using eribulin in patients with breast cancer, associated with brain metastasis: the scientific background and the Russian clinical experience

L. Bolotina, V. Gorbunova, S. Khokhlova, 2019, Journal of Modern Oncology.